Genknowme now reimbursed by KPT

Genknowme, the Swiss epigenetics startup, has secured formal reimbursement from KPT — one of Switzerland’s leading health insurers. This marks a meaningful step for prevention and personalized health.

Genknowme offers blood-based epigenetic tests that assess an individual’s “biological age,” reflecting how lifestyle factors (diet, exercise, smoking, etc.) influence gene expression and long-term health. With KPT’s support, the company’s preventive health assessments become more accessible, potentially enabling many more insured individuals to benefit from insights on how to improve their long-term health through lifestyle changes.

This development reinforces Genknowme’s growing role in preventive and personalized medicine — and illustrates a shift in the Swiss healthcare model towards prevention.